In this Review, we discuss how mutations and modifi cations that interfere with normal mechanotrans duction and cellular sensitivity to mechanical stress could be implicated in a wide spectrum of diseases that range from loss of hearing to muscular dystrophies and cancer (TABLE 1) . Many of these diseases share few similarities at first sight. How could muscular dystrophies be related to atherosclerosis or kidney failure? We will highlight some of these disorders and discuss how they could be traced back, at least in part, to defects in mechano transduction, revealing some unexpected similarities. A common denominator of many mechanobiology diseases is a disruption in the intricate force transmission between the extracellular matrix (ECM), the cytoskeleton and the interior of the nucleus (FIG. 2) . Cellular mechano sensing is based on forceinduced conformational changes in mechanosensitive proteins that are subject to molecular forces that result in opening of membrane channels or altered affinities to binding partners, thereby activating signalling pathways. Hence, any changes in normal intra cellular force transmission through changes in cellular (or extracellular) structure and organization can lead to altered molecular forces acting on these proteins, result ing in attenuated or increased mechanosensitive signals. In addition to the defects that affect cellular structure and organization, and thus cellular mechanosensing, muta tions in proteins that are involved in the downstream signalling pathways can also cause impaired mechano transduction. Examples include mutations in proteins that are involved in intracellular calcium signalling or members of the Rho or mitogenactivated protein kinase (MAPK) pathways 2 . Generally, any changes in cellular or extracellular structure, the cellular mechanosensing process itself or the subsequent downstream signalling pathways can result in altered and abnormal mechano transduction and lead to disease (FIG. 3) . Identifying the molecular details that are involved in normal and defec tive mechanotransduction will lead to a better under standing of the underlying disease mechanisms and normal cellular function and may provide us with new avenues of therapeutic approaches for these diseases.
Cells need to feel the force All cells and organisms across the evolutionary spec trum, from the most primitive to the most complex, are mechanosensitive 3, 4 . This 'universal' property allows cells to relay mechanical stimuli from their physical surroundings or from within the organism to electro chemical or biochemical signals, which then regulate a wide repertoire of physiological responses. As such, mechanotransduction -be it involved in sensing exter nally applied forces (for example, in touch sensation) or in regulating forces and tension in the body (for example, in muscle tension or regulation of blood pressure) -is essential to developmental pathways and to normal tissue homeostasis, primarily in the maintenance of tissues in which cellular adaptive responses are crucial to counter act substantial variations from normal conditions 4, 5 . For example, muscle tissue responds to exercise with hyper trophic growth -that is, there is an increase in cell size. The vascular system can maintain a constant blood pres sure despite changes in cardiac output by vasoconstric tion and vasodilation (the contraction or relaxation of the smooth muscle cells that surround blood vessels).
one often cited example of mechanotransduction is its role in hearing and balance, which results from electro chemical responses to sound waves, pressure and gravity (see Review by Chalfie 89 in this issue). These mechanical forces cause small displacements in the stereo cilia of hair cells in the inner ear. The deflection of the stereocilia causes tension in the tip links, small extracellular fila ments that connect the tips of stereocilia with adjacent stereocilia, thereby pulling open mechanicallygated ion channels (FIG. 1) . The rapid influx of calcium and other ions can then initiate further downstream signalling. Motor proteins that are located at the distal ends of the tip links can relax or contract to restore resting tension, thus providing a mechanism to allow the system to adjust to dynamic stimulation 6 . similarly, mechanotransduction is pivotal to touch sensation and proprioception (the internal sensing of the relative position of one's body parts), which have similar underlying mechanisms for mechanotransduction signalling as hearing 7, 8 . Mechanotransduction also has a fundamental role in regulating physiological phenomena in other specialized tissues that are not directly involved in sensory func tions. For example, skeletal and cardiac muscles can respond to increased load such as intensive resistance exercise, with hypertrophic growth, whereas immobil ized muscles will atrophy over time 9 . The role of regula tory mechanotransduction in the cardiovascular system is particularly fascinating. It is now well established that the morphology and physiology of the heart and vascu lature are influenced by pressure and shear stress that are generated from flowing blood [10] [11] [12] [13] , and low inter stitial flow rates are sufficient to stimulate lymphangio genesis 14 . sophisticated in vivo studies in zebrafish embryos have revealed that distinct highshear flow pat terns are present during crucial stages in the developing heart: artificially perturbing the shear forces by occlusion results in abnormally formed hearts (for example, abnor mal third chamber, reduced looping or defective valves), with defects that are similar to those that are observed in some congenital heart diseases 15 . In the mature cardio vascular system, it is thought that laminar shear stress and circumferential vessel stretch exert an atheroprotec tive effect on endothelial cells. Consistent with this idea, atherosclerotic lesions are often found at specific sites of disturbed (that is, turbulent) flow patterns, characterized by low and oscillatory shear stress at the endothelium (see the Review by Hahn and schwartz 90 in this issue).
Box 1 | Cellular mechanotransduction
Several biological components, not mutually exclusive, have been proposed to act as cellular mechanosensors and are schematically depicted in a representative cell (see figure) . Note that most of these features can be found in many cell types, although some (for example, changes in intercellular space) might only be relevant in a subset of cells. Another example for the role of mechanotransduc tion in tissue maintenance is bone. Compact bone is comprised of concentric layers of bone matrix, in which small cavities known as lacunae are interspersed at regular intervals. These lacunae harbour osteocytes and are connected through canaliculi, a network of inter connecting canals. Gravity and compressive forces that are generated by muscle contractions during locomotion result in small deformations of the poroelastic bone, resulting in pressure gradients that drive inter stitial fluid flow through the lacunae-canalicular network. This loadinduced fluid flow is thought to stimulate localized bone remodelling and optimize the physical performance of the bone through mechanotransduction signalling 16 . likewise, chondrocytes (the main cells that comprise cartilage) adapt to widely varying stresses by secreting a glycosaminoglycanrich ECM that gives cartilage its dynamic mechanical properties. Moreover, lung physiology from development through maturation is influenced by the continuously changing mechanical stress and strain that is caused by the cyclic distension and contraction of the lungs 17 . similarly, urine flow inside the kidney tubules has a central role in regulating kidney morphogenesis, as these cells sense fluid shear stress by the bending of primary cilia 18 .
Mechanotransduction and disease
The ability of cells to respond to changes in their physical environments is crucial in the development and main tenance of tissues that are exposed to varying mechani cal stress (for example, muscle and bone), but also in physio logical processes that affect the entire organ ism (for example, control of blood pressure and blood flow). on the cellular level, mechanotransduction can modulate diverse functions such as protein synthesis, secretion, adhesion, migration, proliferation, viability and apoptosis. Consequently, defects in cellular mech anotransduction -often through inherited or acquired mutations -can result in, or can at least contribute to, various human diseases (TABLE 1) . Alternatively, changes in the cellular physical environment can elicit patho logical consequences, even when the cellular mechano transduction processes function properly. Examples for this scenario include disturbed fluid shear stress at bifurcations that trigger vascular remodelling, which can result in the development of atherosclerosis 19 , or the loss of bone mass in conditions of microgravity 20 . In these cases, it is the abnormal mechanical stress at the cellular level that -through (normal) mechanotransduction signalling -modulates cellular processes that can result in the breakdown of normal tissue function. so what diseases can arise from defects in mechano transduction? As almost all cells rely on mechanotrans duction signalling for normal function, many tissues can be affected by impaired biomechanics or mechanosensing. An obvious example is loss of hearing that is caused by muta tions in the deafness genes that encode mechanosensi tive proteins 6 (FIG. 1) . other examples of affected tissues include bone 16, 20 , cartilage, the lung [21] [22] [23] , the immune sys tem [24] [25] [26] and the central nervous system 27, 28 . Below, we focus on mechanotransduction defects in skeletal and car diac muscle that result in muscular dystrophy or cardio myopathies [29] [30] [31] , and also briefly discuss defects in the eye.
Cardiac mechanosensing and hypertrophy. More than 400 different mutations have been identified in patients with cardiomyopathy, affecting 9 separate sarcomeric genes, including actin, αtropomyosin, troponin, titin and, most commonly, βmyosin heavy chain 32 . To understand how mutations in these structural proteins can result in patho logical hypertrophy, it is helpful to view these proteins in the context of cardiac mechanotransduction. 
Stretch-sensitive ion channels
Ion channels that can change their conformation from closed to open in response to mechanical strain in the membrane.
Sarcomeres
Basic functional units in striated muscle cells, consisting mostly of thick myosin filaments and thin actin filaments to generate forces.
Aortic stenosis
A condition that is characterized by abnormal narrowing of the valve opening between the left ventricle and the aorta in the heart, restricting blood flow and impeding the ability of the heart to pump blood to the body.
Ventricular wall stress
The mechanical stress, that is force per unit area, in the myocardium. Decrease in wall thickness, following loss of myocytes after infarction can result in increased left ventricular stress and can damage the remaining myocytes.
Cardiac myocytes can respond directly to mechani cal deformation or stretch through several internal mechanosensors, although the precise mechanosens ing mechanisms often remain incompletely understood. The presumptive mechanosensors include stretchsensitive ion channels at the cell membrane, integrins and integrinassociated proteins (such as melusin or integrinlinked kinase (IlK)) sarcomeric proteins (such as titin, myosin or the small lIMdomain protein MlP) and cellsurface receptors (such as Gproteincoupled receptors (GPCRs) and angiotensin II type 1 receptors) that can be activated by stretch even in the absence of ligands. These mechanosensors activate multiple and overlapping cellular signalling pathways that include Ras/Rho and MAPK signalling, phospholipase C activ ation, calcium/calcineurinmediated signalling and microRnAs 32 (FIG. 4) . These pathways trigger the expres sion of hypertrophic genes and cause an increase in myocyte length and/or width (reviewed in REFS 32, 33) . These mechanotransduction pathways, along with often overlapping neurohormonal mechanisms (for example, GPCR signalling that is activated by angiotensin or cat echolamines) allow the heart to adapt to prolonged changes in the mechanical workload with an increase in cardiac myocyte size (hypertrophy) and modifica tion of the surrounding ECM, referred to as cardiac remodelling.
The cardiac hypertrophic response is often catego rized into physiological or pathological hypertrophy. Physiological hypertrophy, which arises as a conse quence of aerobic exercise or pregnancy, is characterized by the addition of sarcomeres in series (to lengthen the cells) and in parallel (to increase cell width), resulting in increased cardiac wall thickness and chamber dimen sions to adapt to the elevated haemodynamic load.
By contrast, pathological hypertrophy is caused by abnormal changes in the cardiac workload, for exam ple through hypertension, aortic stenosis, myocardial infarction or by congenital defects that are due to muta tions in genes that encode sarcomeric proteins. As in physiological hypertrophy, cardiac myocytes sense the increased ventricular wall stress and respond with an increase in cell size. However, in pathological hyper trophy, myocytes often show a disproportional increase in either width, resulting in increased ventricular wall thickness, or length, leading to a dilated ventricle. The hypertrophic response is initially beneficial as it nor malizes ventricular wall stress and is thus often referred to as compensatory hypertrophy 9, 34 . However, elevated stress levels that persist over extended time periods often lead to maladaptive remodelling of the myocytes and ECM, which is accompanied by myocyte apoptosis and necrosis and eventually results in cardiac failure 32 . The precise molecular mechanisms that govern the transition from compensatory hypertrophy to patho logical remodelling remain incompletely understood. several lines of evidence suggest that hypertrophy can further destabilize cardiac mechanics, as hypertrophic tissue is often characterized by impaired contract ility and relaxation dynamics. In addition, the cellular programme that is responsible for pathological hyper trophy results in the reexpression of genes that are normally associated with the embryonic myocardium. This causes disorganized cellular structure, impaired calcium dynamics and increased interstitial fibrosis, worsening the mechanical imbalance between cardiac function and haemodynamic load 35 . The maladaptive remodelling of the ECM can also result in slippage of cardiac myocytes, further exacerbating the mechanical imbalance in the myocardium. Encouraging findings in animal models of cardiac hypertrophy suggest that pathological hypertrophy can be prevented or even reversed by modulating signalling pathways that are involved in the hypertrophic response, motivating the search for specific pharmacological modulators 32, 33 . The challenge in developing these therapeutic approaches lies in unravelling the dichotomy of physiological and compensatory hypertrophy on one hand and patho logical hypertrophy on the other, as significant overlap exists between the signalling pathways that are involved in these processes.
Mechanotransduction and muscular dystrophies. In skeletal muscle cells, forces that are generated in the sarcomeres are transmitted to the ECM through a specialized protein complex that consists of dystrophin and the dystrophinassociated protein complex in the plasma membrane (FIG. 2) , thereby shielding the cell membrane from excessive stress. In Duchenne muscular dystrophy, mutations in the dystrophin gene disrupt the force transmission between the cytoskeleton and the ECM, resulting in progressive muscle degeneration 36 . Importantly, the disruption of cytoskeletal-ECM cou pling not only renders cells more susceptible to mem brane damage, but also causes aberrant activation of MAPK extracellular signalregulated kinase 1 (ERK1) and ERK2 signalling in response to stretch 37 . This abnormal mechanotransduction signalling could fur ther impact cell function and viability. Recent experi ments indicate that in dystrophindeficient muscle fibres, stressinduced rupture of the more fragile plasma membrane allows influx of extracellular calcium. This causes abnormal muscle contraction and, combined with the defective coupling between the cytoskeleton and the ECM, leads to physical damage of the cytoskel eton, which subsequently results in the loss of muscle cells 38 . Interestingly, dystrophin is also involved in the endothelial cell response that is necessary for the fluid shearstressmediated dilation of arteries. Consequently, endothelial cells from dystrophindeficient mice have impaired mechanotransduction signalling in response to fluid shear stress, resulting in attenuated dilation of arteries and a decreased vascular density in cardiac mus cle, which could further contribute to the progressive loss of muscle 39 . similarly, mutations in the cytoskeletal proteins desmin, titin and myosin, which are important sarcomere components, result in disorganized sarcomeres and disturbed cellular mechanics, including impaired force generation and altered (passive) cytoskeletal stiffness, which can impair relaxation dynamics of myocytes. The deleterious effects of these mutations can result from direct changes in intracellular force distribution and/or generation due to ultrastructural disorganization, but can also arise from downstream effects of altered cell ular mechanosensing, as myosin and titin can function as mechanosensors 40 . Investigating the relative contri butions of these mechanisms to muscular dysfunction may provide important clinical insights, as defects in mechano transduction pathways could potentially be attenuated with pharmacological reagents. This research is hampered, however, by the fact that mechanotransduc tion can directly influence cellular structure and function, making it difficult to discern cause and effect.
The recent findings that muscular dystrophies can arise from mutations in nuclear envelope proteins (namely lamins A and C, emerin or nesprins) further highlight the concept that disturbed intracellular struc ture and force transmission can contribute to muscu lar disease. Although these proteins are expressed in most differentiated cells, the resulting phenotypes are often muscle specific and suggest that cells of affected patients have an increased sensitivity to mechanical stress. new insights have come from a mouse model of Emery-Dreifuss muscular dystrophy that lacks lamins A and C. Cells from these animals are character ized by decreased nuclear stiffness, increased nuclear fragility and impaired activation of mechanosensitive genes, causing decreased viability in cells subjected to repetitive strain 41 . The increased nuclear fragility could result in nuclear rupture and cell death in mechani cally stressed tissues. However, nuclear rupture can only explain a fraction of the cell death that is observed during repetitive strain application, especially in cells from emerinnull mice, which have normal nuclear mechanics and increased straininduced apoptosis 42 . Therefore, it is likely that the attenuated expression of mechanosensitive, antiapoptotic genes, such as Iex1, contributes to the increased cellular sensitivity to mechanical stress 41, 42 . Currently, it remains unknown what causes the mechanotransduction defects in these cells. Although the nucleus has often been proposed as a cellular mechanosensor -for example, by altering chromatin accessibility in response to deformations -direct evidence for this function is still elusive, Extracellular forces are transmitted through the extracellular matrix (ECM), which consists of tissue-specific proteins such as collagen, laminin and fibronectin. Adhesion complexes at the cell surface physically link the ECM to the cytoskeleton. For example, focal adhesions, comprised of integrins, talin, vinculin and other proteins, connect the ECM to actin filaments. In skeletal muscle, the dystrophin-associated protein complex links the ECM to actin filaments. The configuration and binding affinity of these complexes can be modulated through intra-and extracellular signalling. Intracellular forces are then transmitted through the cytoskeletal network (that is, actin filaments, microtubules and intermediate filaments). The cytoskeleton is coupled to the nucleus through nesprins and possibly through other proteins on the outer nuclear membrane. The giant isoforms of nesprin 1 and nesprin 2 bind to actin filaments, whereas nesprin 3 can associate with intermediate filaments through plectin. Nesprins interact across the luminal space with inner nuclear membrane proteins (for example, SUN1 and SUN2) that are retained there by interaction with other nuclear envelope proteins such as lamins and emerin 84 . Nuclear lamins and SUN proteins also bind to nuclear pore complexes, which could contribute to nuclear cytoskeletal coupling. Finally, lamins form stable nuclear structures and can bind to DNA, thus completing the force transmission between the ECM and the nuclear interior. Mutations in any of these components, as well as changes in cellular structure and organization or changes in the cellular environment, could disturb mechanotransduction signalling and result in altered cellular function. However, this has only been conclusively demonstrated for a subset of these molecules, motivating further research. 
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Altered mechanotransduction signalling
Cellular sensing and signalling
Disease Changes in
Haemodynamic load
The forces that are generated from cardiac output and physical resistances due to the flow of blood in circulation.
Glaucoma
A disease in which the optic nerve is permanently damaged due to abnormally high fluid pressure in the eye. Results in impaired or complete loss of vision.
Axial myopia
Near-or short-sightedness associated with an increase in the eye's axial length.
Intraocular pressure
The pressure inside the eyeball that is generated by resistance to the outward fluid flow of aqueous humour. This pressure helps maintain the shape of the eye, but can result in glaucoma if it is too high.
and future research has to address whether defects in mechano transduction signalling arise as a direct con sequence of altered nuclear stiffness or whether they mainly reflect broader defects in specific signalling pathways (for example, in nuclear factorκB signalling) that are modulated by nuclear lamins.
Trouble in the eye. Another unexpected organ that is affected by disturbed mechanotransduction is the eye. several recent findings suggest that modulated mechano transduction signalling due to increased mechanical stress could significantly contribute to the pathogenesis of glaucoma and axial myopia 43 . In glaucoma, elevated hydrostatic pressure and altered biomechanics of the optic nerve head could initiate mechanisms that result in loss of vision. Recent experi mental evidence suggests that human (and monkey) eye tissues deform in response to even minute changes in intraocular pressure 44 . In addition, ambient hydrostatic pressure elevations resembling intraocular conditions in glaucoma can induce apoptosis of retinal ganglion cells in vitro, consistent with in vivo findings 44 . Moreover, human scleral fibroblasts (the primary cells that are implicated in the scleral remodelling that accompanies axial elongation during the development of myopia) express many genes that are modulated by mechani cal strain application. These include genes that encode ECM proteins (such as tenascin C), protein kinases (such as human lymphocytespecific protein tyrosine kinase (lCK)), cell receptors (such as parathyroid hor mone (PTH)/PTHrelated peptide (PTHrP) receptor), cell growth and differentiation factors (such as fibro blast growth factors and bone morphogenetic proteins) and transcription factors (such as jun B) 45 . Although the role of some of these proteins in ocular deve lop ment and axial elongation is obscure and rather specu lative, the contribution of others is more obvious. For example, activation of the PTH/PTHrP receptor by calciumregulating hormones triggers several intra cellular signalling events including the activation of protein kinase C, which is directly involved in scleral remodelling. Moreover, tenascin C, which has been implicated in tissue remodelling during development, can act as a mediator of the scleral response to stretching by increasing the synthesis of proteolytic enzymes that affect ECM remodelling. These findings suggest that increased intraocular pressure -mediated by nor mal mechanotransduction signalling in scleral fibroblasts -can contribute to the abnormal remodelling that occurs in axial myopia. Altered cellular mechanotransduction signalling can be caused by changes in the extracellular environment (for example, variations in the mechanical forces or deformations that are experienced by the tissue, or changes in extracellular matrix (ECM) composition that affect its stiffness and biochemical properties), the structure and organization of a cell, or the elements of the mechanotransduction process itself. Changes in cellular structure and organization often result from inherited or de novo mutations in proteins that are part of the force-generating machinery, the cytoskeletal network or the nuclear envelope and interior. This category also includes transmembrane proteins that are involved in cell-cell or ECM-cell adhesion. Abnormal function of these proteins can alter the intracellular force distribution and thus mechanotransduction signalling. By contrast, defects in the cellular mechanosensors can disturb mechanotransduction signalling even in the case of normal force distribution. Many proteins can fall into more than one category, as structural proteins can also have mechanosensing capabilities and mechanotransduction signalling can in turn cause changes in cellular structure and organization as well as in the extracellular environment. Importantly, mechanical activation often initiates multiple signalling pathways at once, and these can have significant overlap and crosstalk, making it difficult to study specific pathways. Several of the signalling pathways are often shared with 'classical' receptor-mediated pathways. For example, the mitogen-activated protein kinase (MAPK) pathway can be turned on by mechanical strain as well as by receptor-linked tyrosine kinases (for example, by the epidermal growth-factor receptor). Ultimately, excessive and prolonged disturbances in normal mechanotransduction signalling can result in disease conditions. NF-κB, nuclear factor-κB. Development and premature ageing Mounting evidence suggests that mechanotransduction also has a crucial role in development [46] [47] [48] [49] . Thus, any disturbances to normal mechanotransduction mecha nisms or to a cell's physical environment can result in broad developmental defects 50 . A classical example to illustrate this is Kartagener's syndrome, which is char acterized by a left-right reversal of the primary vis ceral organs. left-right patterning in early mammalian embryos is dictated by ciliadriven leftward fluid flow during gestation, which -through mechanotrans duction signalling -differentially induces expression of nodal, a transforming growth factor (TGF)family molecule, and a signalling cascade of other factors in the left side of the embryo. Mutations in the dynein motor proteins that are primarily responsible for Kartagener's syndrome block cilia motion in the epi thelium of a midline node in the embryo and thus pre vent the leftward fluid flow; in the absence of flow, the left-right patterning becomes random. similarly, mutations in the genes that encode the ciliary proteins polycystin 1 or the transient receptor potential channel family protein polycystin 2 (TRPP2) provide direct evidence for defects in mechanotrans duction that result in kidney disease 51 . Polycystins form mechanosensitive ion channels in the cilia of renal epithelial cells and allow influx of calcium in response to flowinduced bending of the cilia, thus act ing as a cellular flowsensor in the kidney 51 . Polycystin mutations that are associated with loss of function leave cells unable to sense the fluid flow that normally regulates kidney morphogenesis, resulting in several types of polycystic kidney disease (PKD) that include autosomal dominant PKD, a disease characterized by progressive cyst formation that culminates in kidney destruction 51, 52 . Disturbed mechanotransduction can also under lie several other diseases that are not traditionally approached from a biophysical perspective. one such example is Hutchinson-Gilford progeria syndrome (HGPs), a progeroid disorder that is caused by muta tions in the LMNA gene, which encodes lamin A. Patients with HGPs appear normal at birth, but fail to thrive shortly thereafter and die in their early teens. Arteriosclerosis is the leading cause of death in patients with HGPs 53 , and postmortem analysis of vascular tissue from patients with HGPs and from a mouse model of HGPs have revealed extensive loss of vascu lar smooth muscle cells and an unusual susceptibility to haemodynamic stress 54, 55 . Mechanotransduction in vascular cells in response to fluid shear stress and strain from vessel expansion is a crucial protective mecha nism against arteriosclerosis and can mediate apoptosis, proliferation and ECM secretion in healthy vascular smooth muscle cells 56 . Recent experiments from our laboratory revealed that fibroblasts from patients with HGPs have decreased viability when subjected to repetitive mechanical strain, and that cells from patients with HGPs lack the straininduced prolifera tion response that is seen in cells from healthy con trols 57 . These findings suggest that increased cellular sensitivity of vascular cells subjected to normal fluid shear stress and vessel expansion could be a possible mechanism for the progressive loss of smooth muscle cells and severe arteriosclerosis in patients with HGPs. Although increased cellular sensitivity to mechanical strain is certainly not the only factor in HGPs, our experiments suggest that it could have an important role in the development of severe arteriosclerosis that leads to lethal stroke or myocardial infarction in human patients 55 . Furthermore, it could contribute to defects in other mechanically loaded tissues, perhaps causing the bone abnormalities and skeletal muscle dystrophy that are characteristic of HGPs. Cardiac myocytes respond to altered haemodynamics by activating multiple intracellular signalling pathways that are implicated in the maintenance and regulation of cardiac myocyte function. Mechanical loading can be sensed by cardiomyocytes through a diverse group of membraneanchored mechanosensors including stretch-activated ion channels, cell-membranespanning G-protein-coupled receptors, growth-factor receptors and integrins. This mechanical sensation is then converted to biochemical signals by triggering the multi-step activation of downstream partners in an array of signalling cascades in the cytoplasm. The highlights of such cascades include the three modules of the mitogen-activated protein kinase (MAPK) family underscored by the activation of Ras, the Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, Rac activation, calcium (Ca 2+ ) and nitric oxide (NO) signalling. The convergence of these pathways results in the activation of select transcription factors including nuclear factor-κB (NF-κB) and nuclear factor of activated T cells (NFAT), which then translocate to the nucleus and modulate the expression of a panel of mechanosensitive genes including Egr1 and Iex1. Ultimately, the net sum of gene-expression reprogramming in cardiomyocytes dictates the functional response of a cell to mechanical stress.
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Soft matrix
Rigid matrix Cancer cells have lost their touch Perhaps the most intriguing of all of the mechano transduction diseases is cancer. In the past decade, sudden changes in ECM mechanics, ECM remodelling and the resultant disturbance in cytoskeletal tension and mechano transduction signalling have emerged as important factors that can promote malignant transform ation, tumorigenesis and metastasis [58] [59] [60] . In addition to a combination of genetic mutations and increased oncogene activity, cytoskeletal reorganiza tions -particularly those that are manifested by alter ations in the tensional force that is generated by the actin-myosin apparatus in the cell -play a pivotal role in the morpho logical changes that are adopted by tumour cells as they develop invasive phenotypes. one of the main regulators of cytoskeletal tension is the Rho family of GTPases. Among its many targets, Rho functions via Rho kinase (RoCK) to regulate myosin light chain phosphorylation through inhibitory phos phorylation of myosin phosphatase. Although studies on Rho activity in tumours have yielded contradictory results (some reports provided substantial evidence supporting the notion that tumours have increased Rho activity and exhibit more cytoskeletal tension whereas others reported decreased Rho activity in solid tumours [61] [62] [63] [64] [65] [66] ) it has become apparent that cytoskeletal tension significantly impacts signalling pathways that are implicated in cancer progression. Discrepancy in these studies may be partly attributable to the multi variant experimental conditions that were used and to the limitations that are associated with two dimensional (2D) monolayer cell cultures.
Furthermore, several studies have shown that cytoskeletal tension in tumours is influenced by ECM stiffness 2, 58, 67 . Tumours are generally much stiffer than the surrounding normal tissue. Concurrent changes in tissue stiffness, tumour growth due to proliferating cells and/or elevated interstitial fluid pressure all combine to affect the physical environment of cancerous cells inside the tumour and the adjacent normal cells 68 . This altered physical environment can modulate the fate of these cells through mechanotransduction (FIG. 5) . For example, higher ECM stiffness can result in disrup tion of normal epithelial cell polarity, inducing mam mary epithelial cells to fill the cystic lumens in breast cancer 2 . Paszek and coworkers investigated whether the increased tissue stiffness that is observed in mam mary tumours in 3D matrices promotes the malig nant pheno type by influencing integrins, cellsurface receptors that connect specific ECM molecules to the cytoskeleton 2 (FIG. 2) . They found that matrix stiffness (exogenous force) and cytoskeletal tension (endogenous force) functionally cooperate in a 'mechanocircuit' that modulates phenotypic transformations in tumours by coupling the mechanosensing role of integrins in relaying external physical cues to Rho and ERK sig nalling pathways. As such, the stiffer matrix disturbs epithelial morphogenesis by causing forcedependent aggregation and clustering of integrins, thus resulting in elevated Rho-RoCKdependent cytoskeletal ten sion, which amplifies the formation and stabilization of focal adhesion assembly. This increase in cellgenerated force and in focal adhesion assembly was accompanied by focal adhesion kinase signalling, RoCKmediated Schematic representation of how increased extracellular matrix (ECM) stiffness and altered cytoskeletal tension can contribute to tumour formation. Increased ECM stiffness can arise from fibrosis or in response to increased cytoskeletal tension, caused, for examples, by oncogene (Ras)-driven extracellular-signal-regulated kinase (ERK) activation. The increased ECM stiffness is sensed by focal adhesions and activates integrins and focal adhesion kinase, thereby promoting focal adhesion assembly and stimulating the Rho-ROCK (Rho kinase) pathway. ROCK activation increases cytoskeletal tension by increasing myosin light chain (MLC) phosphorylation, which can result in further increases in ECM stiffness due to cellular mechanotransduction signalling, completing a self-enforcing (positive) feedback loop. Crosstalk between the Rho-ROCK pathway and the epidermal growth-factor receptor (EGFR)-Ras-ERK pathway, as well as modulation of growth-factor-dependent ERK activation by integrins, results in increased proliferation. ERK activation can also increase cytoskeletal tension through ROCK, further complementing the crosstalk between cytoskeletal tension and proliferative pathways. In breast cancer cells, the combined action of increased contractility and proliferation, triggered by increased ECM stiffness, may drive the undifferentiated and proliferative phenotype of mammary epithelial cancer cells and result in tumour formation. Decreasing Rho-mediated cytoskeletal contractility or ERK activity is sufficient to revert EGFR-transformed cells that form disorganized and invasive colonies into phenotypically normal cells that form polarized and growth-arrested acini in three-dimensional culture 
Pleural effusions
Fluids that collect in the space between the lungs and the chest wall. disruption of adherens junctions, enhanced growth factordependent ERK activation driving tumour cell proliferation and disruption of basal polarity, hence abrogating lumen formation and remodelling mammary tissue architecture. Disrupting Rho or ERK signalling to reduce cytoskeletal tension to normal levels resulted in significant reduction in tumour cell proliferation and in repression of the malignant phenotype. Recent experi ments also demonstrated that both integrins and Rhomediated regulation of intracellular tension are needed to promote the invasive behaviour of fibroblasts and cancer cells in cocultures 69, 70 . All cells, with the exception of haematopoietic cells, need to adhere to a solid substrate for normal cellcycle progression and survival. notably, cancer cells lose this dependency on anchorage and cellsurface tension as they become able to invade other tissues 71, 72 . This hall mark of metastatic cells, that is, their ability to break through the basal lamina, infiltrate blood vessels, exit the blood vessels and form new tumours, requires finely regulated biomechanical interactions between the cancer cell and its physical milieu. For example, adhesion of melanoma cells to the endothelial cells that line blood vessels (a crucial step to extravasation and metastasis) is in part regulated by the hydrodynamic shear rate, which mediates melanoma-leukocyte aggre gation thereby enhancing adhesion of tumour cells to the endothelium 73 . Moreover, although tumours are stiffer, metastatic cells can be distinguished from non invasive cancer cells and from normal cells by reduced cytoskeletal stiffness and increased deformability 60, 74, 75 . Recent evidence suggests that cell deformability strongly correlates with passage time through narrow pores and with enhanced metastatic potential in mouse melanoma cells 76 . Thus, increased cellular and nuclear deformability can enable the passage of metastatic can cer cells through sizelimiting pores and blood vessels, resulting in enhanced metastatic spreading. Although some of these studies to measure the stiffness of cancer cells had technical limitations (for example, measure ments of normally adherent cells were performed in suspension, or only a small number of cells were tested), the experiments illustrate that many cancer cells are characterized by altered physical properties and that biomechanical measurements of cells isolated from pleural effusions may have significant diagnostic and prognostic value.
Clearly, cancer is not exclusively caused by defective mechanotransduction signalling, as deregulation of cell cycle control, defects in DnAdamage repair, suppression of apoptosis and altered adhesion and/or migration all contribute to this multifaceted disease. However, many of the cellular functions that are involved in tumor igenesis and metastasis are modulated by mechano transduction. Hence, altered mechanotransduction signalling may be an important component in tumour formation and metastatic progression. Improved cell culture modalities that would permit the study of tumour progression in a 3D context would greatly enhance our ability to deci pher the effects of mechanotransduction aberrations in cancer progression.
Conclusions and future perspectives
The above examples demonstrate that the mechano transduction feedback loops that couple cellular struc ture and function, and that modulate cellular structure and the extracellular environment, play an important role in the maintenance of normal tissue function. Moreover, events that disrupt these feedback loops, either by affecting cellular mechanosensing, intra cellular mechanotransduction signalling or intracellular or extracellular force distribution, can result in various clinical phenotypes.
one challenge that remains is to determine the effects of defective structural or motor proteins on mechanotransduction. often, structure, function and mechanotransduction are tightly linked, as the examples of myosin, titin (both recently identified as potential cellular mechanosensors), talin and lamins illustrate. Talin and vinculin are structural components of the focal adhesion complex, linking integrins to actin filaments (FIG. 2) . Molecular dynamic models suggest that forceinduced conformational changes in talin can activate a cryptic vinculin binding site, enabling subse quent recruitment of vinculin to reinforce focal adhe sion sites 77 . similarly, lamins were first identified as nuclear intermediate filaments, but were subsequently shown to have an important role in transcriptional regu lation as well as in DnA and RnA synthesis 78 . These examples highlight our still limited understand ing of the cellular structure-function relationshipsthat is, we still do not fully understand how the 3D organization of the cytoskeleton and the nucleus affect cellular functions such as DnA and RnA transcription. Future research should focus on how changes in intra cellular structure, through induced deformations or remodelling for example, can modulate these cellular functions and processes.
understanding these processes may also provide us with new clues in the search for the elusive cellular mech anosensors and the question of how cells manage to sense their physical surroundings. The many reports of putative mechanosensing proteins suggest that multiple mecha nisms exist, even in single cell types, so that the interplay of redundant or complementary mechano transduction pathways has to be viewed in a 'systems biology' context 3 . This will be especially important when designing treat ment approaches for mechanotrans duction diseases. Although mutations in structural proteins may require the replacement of affected genes or cells by targeted gene or stemcell therapy -currently a challenging and daunting task -an alternative approach for at least some of these diseases could be to correct downstream signal ling pathways that are disturbed by altered mechano transduction signalling. For some dominantnegative mutations, another strategy could be based on the pos sible redundancy of related proteins; it might be possi ble to reduce levels of the mutant protein using RnA interference. such an approach has been proposed for a lamin A mutation that is associated with HGPs, as studies in a lamin Adeficient mouse model suggest that lamin C might be sufficient to maintain cellular function without an increase in cellular sensitivity 79 . Alternatively, some cellular mechanical defects can potentially be directly addressed using small molecules approaches. For exam ple, the membrane sealant poloxamer 188 has been suc cessfully used to reduce damage to the plasma membrane in a mouse model of Duchenne muscular dystrophy, resulting in significant improvement in cellular function in cardiac and skeletal muscle 80, 81 . The past years have provided increasing evidence that the finely tuned feedback between cells and their physi cal surroundings is crucial for many important cellular functions, ranging from differentiation to proliferation and viability. Events that interfere with these cellular mechanotransduction processes may thus result in dis eases that affect various tissues and organs. studying the mechanisms that underlie these diseases may lead us to new treatment strategies, improved tissueengineering design and enhanced biomaterials, and will also provide us with an opportunity to learn more about mechano transduction and mechanobiology in normal cells and physiology.
